Health and Pharmaceuticals

CSL completes Novartis flu business

by AAP
0 Comments
Biotech giant completes $US275m ($376.1m) takeover of Novartis' influenza business.

The logistics of a changing health landscape

0 Comments
The $485 million funding announcement for electronic health records contained within the recent federal budget opens the door to some interesting opportunities for Primary Health Networks.

ResMed to soothe China's sleepless

0 Comments
Sleep disorder device supplier to expand in China, on track to meet its 2020 goals.

Jangho takes 20% stake in Vision Eye

0 Comments
Primary Health sells down $34m stake in Vision for $14m windfall to Chinese manufacturer.

CSL cleared for Novartis buy

0 Comments
Group wins approval for $US275m purchase of Novartis' influenza business.

What Australia's missing in global trade

0 Comments
The nation ranks 116th in a measure of global competitiveness and the result is hurting the advanced manufacturing sector.

Medical roll-up could unravel

Mixed success with medical roll-ups has some investors cautious about the next to hit the market — Lake Imaging.

Novogen acting CEO flags review

0 Comments
Iain Ross moves to reassure shareholders, announces company-wide review of pre-clinical programs.

GSK reports slump in quarterly profit

by AFP
0 Comments
Chief executive labels drugmaking giant's results 'encouraging' given the business has slimmed down.

Medlab shares up on cannabis approval

by AAP
0 Comments
Shares in MedLab Clinical surge after it announces NSW government approval to conduct medicinal cannabis research.

Medics in stoush with private insurers

0 Comments
Medical profession 'emotive' in response to row, rather than addressing issues, analysts say.

CSL seeks corporate tax reform

by AAP
0 Comments
Biotech firm suggests highly targeted tax rate of 10% for advanced manufacturing.

Medical marijuana merger complete

by AAP
0 Comments
PhytoTech merges with MMJ Bioscience, creating a listed farm-to-pharmaceutical firm.

Health sector eyes bumper profits

0 Comments
Analysts say Australia’s healthcare sector is set for a bumper reporting season.

US FDA will review CSL treatment

by AAP
0 Comments
Regulators will review CSL's latest treatment for haemophilia, after positive trial.

Teva to buy Allergan Generics for $US40.5bn

0 Comments
Israeli generic drug maker Teva buys Allergan's generics unit to $US40.5bn, in latest drug industry consolidation.

NIA investors burnt as fund sold

0 Comments
Investors in health fund operator NIA likely to lose more than 90% of investment in firm.

The gadget that gives you a low-voltage pick-me-up

0 Comments
A device called Thync stimulates nerves with electricity to fire you up or calm you down, but does it work?

Unilever profit slumps as sales growth slows

0 Comments
Unilever's profit falls 18% in first half as sales growth slowed.

Novogen CEO Kelly resigns

0 Comments
Cancer drug firm chief resigns to focus on other areas of medical research.

Pages